Capital Expenditures for Solventum (SOLV)
According to Solventum's latest reported financial statements, the company's current capital expenditures (TTM) is $379.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
SOLV
Currently viewingCapital ExpendituresSwitch metric
Latest period
$379.00M
YoY change
-0.3%
5Y CAGR
+6.9%
Peak year (2024)
$380.00M
Cumulative capital expenditures
$1.85B
CapEx history chart for Solventum (SOLV) from 2020 to 2025
CapEx history table for Solventum (SOLV) from 2020 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $379.00M | -0.3% | ||
| 2024 | $380.00M | +31.0% | ||
| 2023 | $290.00M | +15.5% | ||
| 2022 | $251.00M | -9.4% | ||
| 2021 | $277.00M | +2.2% | ||
| 2020 | $271.00M | — |
CapEx values are taken from Solventum's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Solventum (SOLV) reported capital expenditures of $379.00M – edged down 0.3% year-over-year.
Across 2020–2025 (5 years), Solventum capital expenditures produced a CAGR of +6.9% – with the latest reading among the more recent periods of the dataset.
Across the available history, capital expenditures reached its high of $380.00M in 2024 and its low of $251.00M in 2022.
Solventum (SOLV) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Solventum Capital Expenditures by Year
Solventum Capital Expenditures 2025: $379.00M
Solventum capital expenditures in 2025 was $379.00M, edged down 0.3% below 2024.
Solventum Capital Expenditures 2024: $380.00M
Solventum capital expenditures in 2024 was $380.00M, surged 31.0% from 2023. This figure represents the highest annual value in the available history.
Solventum Capital Expenditures 2023: $290.00M
Solventum capital expenditures in 2023 was $290.00M, grew 15.5% from 2022.
Solventum Capital Expenditures 2022: $251.00M
Solventum capital expenditures in 2022 was $251.00M, declined 9.4% below 2021. This figure represents the lowest annual value in the available history.
Solventum Capital Expenditures 2021: $277.00M
Solventum capital expenditures in 2021 was $277.00M.
See more financial history for Solventum (SOLV).
Sector peers — CapEx
Companies in the same sector as Solventum, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Solventum's capital expenditures?
- Latest reported capital expenditures for Solventum (SOLV) is $379.00M (period ending December 31, 2025).
How has Solventum capital expenditures changed year-over-year?
- Solventum (SOLV) capital expenditures changed -0.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Solventum capital expenditures?
- Solventum (SOLV) capital expenditures compound annual growth rate is +6.9% over the most recent 5 years available.
When did Solventum capital expenditures hit its highest annual value?
- Solventum capital expenditures reached its highest annual value of $380.00M in 2024.
What was Solventum capital expenditures in 2024?
- Solventum (SOLV) capital expenditures in 2024 was $380.00M.
What was Solventum capital expenditures in 2025?
- Solventum (SOLV) capital expenditures in 2025 was $379.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
SOLV Overview
Company profile, financial tools, and key metrics
SOLV Revenue Counter
Earns $263.98 every second. See per minute, hour, and day.
SOLV Earnings Counter
Earns $49.34 per second net profit. See per minute, hour, and day.
SOLV Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
SOLV What If Invested
What if you had invested $1,000? See historical returns from any date.
SOLV How It Makes Money
Discover visual breakdown of $8.32B in revenue — where it comes from and where it goes.
SOLV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
SOLV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
SOLV Daily Price Character
Steady · 48.6% historical win rate (green days). Streaks & record days.
SOLV Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.